Investigator - Immunology Research Unit

We are looking for a highly motivated and skilled individual to join our Immunology Research Unit at Glaxo Smith Kline as an Investigator. The successful candidate will be required to bring an extensive background in immunological research and have a passion for scientific discovery. The successful candidate will be responsible for planning, executing, and analyzing immunological studies in support of drug discovery and development, as well as providing guidance and mentorship to junior researchers. The ideal candidate will possess a PhD in Immunology and/or related disciplines, with at least 5 years of relevant postdoctoral research experience. The candidate must be able to demonstrate a high level of proficiency in immunological and molecular techniques, including cell culture, flow cytometry, ELISA, qPCR, and gene expression analysis. The candidate should also have a proven track record in designing and executing experiments, data analysis and interpretation, as well as experience in preparing manuscripts and grants. In addition to technical skills, the successful candidate should have excellent communication and organizational skills, as they will be expected to work in a collaborative team environment. This is an exciting opportunity to join a dynamic and innovative research team and make a significant contribution to the development of new drugs and therapies. We look forward to receiving your application.

According to JobzMall, the average salary range for a Investigator - Immunology Research Unit in Cambridge, UK is between £30,000 and £45,000 per year. Salary ranges may vary depending on the qualifications and experience of the individual, the company and the location.

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi.